Pfizer, BioNTech Expand Vaccine Program for Poor Countries
22 September 2021 - 8:46PM
Dow Jones News
By Matt Grossman
Pfizer Inc. and BioNTech SE will expand a program to provide
doses of their Comirnaty Covid-19 vaccine to poor countries at a
not-for-profit price, the companies said Wednesday.
Under the program, the two companies provide doses of their
vaccine to the U.S. government, which pays them a not-for-profit
price and then donates the doses to low- and lower-middle-income
countries and support organizations.
Pfizer and BioNTech will expand the program by 500 million
doses, bringing its total size to one billion doses.
The companies are planning to produce the doses for the program
at Pfizer facilities in Kalamazoo, Mich.; Andover, Mass.;
Chesterfield, Mo. and McPherson, Kan. Delivery of the first 500
million doses began in August, and all one billion are expected to
be delivered by September 2022.
World-wide, the two companies have now shipped more than 1.5
billion COvid-19 vaccine doses in all, they said.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
September 22, 2021 06:31 ET (10:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024
